Inhibition of Gap Junctions Sensitizes Primary Glioblastoma Cells for Temozolomide
Open Access
- 20 June 2019
- Vol. 11 (6), 858
- https://doi.org/10.3390/cancers11060858
Abstract
Gap junctions have recently been shown to interconnect glioblastoma cells to a multicellular syncytial network, thereby allowing intercellular communication over long distances as well as enabling glioblastoma cells to form routes for brain microinvasion. Against this backdrop gap junction-targeted therapies might provide for an essential contribution to isolate cancer cells within the brain, thus increasing the tumor cells’ vulnerability to the standard chemotherapeutic agent temozolomide. By utilizing INI-0602—a novel gap junction inhibitor optimized for crossing the blood brain barrier—in an oncological setting, the present study was aimed at evaluating the potential of gap junction-targeted therapy on primary human glioblastoma cell populations. Pharmacological inhibition of gap junctions profoundly sensitized primary glioblastoma cells to temozolomide-mediated cell death. On the molecular level, gap junction inhibition was associated with elevated activity of the JNK signaling pathway. With the use of a novel gap junction inhibitor capable of crossing the blood–brain barrier—thus constituting an auspicious drug for clinical applicability—these results may constitute a promising new therapeutic strategy in the field of current translational glioblastoma research.Keywords
Funding Information
- Familie Mehdorn Stiftung (Q-026. 0089)
This publication has 53 references indexed in Scilit:
- Cancer Connectors: Connexins, Gap Junctions, and CommunicationFrontiers in Oncology, 2018
- Multidimensional communication in the microenvirons of glioblastomaNature Reviews Neurology, 2018
- Glioblastoma: pathology, molecular mechanisms and markersActa Neuropathologica, 2015
- Biological role of connexin intercellular channels and hemichannelsArchives of Biochemistry and Biophysics, 2012
- Prospective cohort study of radiotherapy with concomitant and adjuvant temozolomide chemotherapy for glioblastoma patients with no or minimal residual enhancing tumor load after surgeryJournal of Neuro-Oncology, 2012
- Current concepts and management of glioblastomaAnnals of Neurology, 2011
- Gap Junction–Mediated Import of MicroRNA from Bone Marrow Stromal Cells Can Elicit Cell Cycle Quiescence in Breast Cancer CellsCancer Research, 2011
- Life cycle of connexins in health and diseaseBiochemical Journal, 2006
- Cost of Migration: Invasion of Malignant Gliomas and Implications for TreatmentJournal of Clinical Oncology, 2003
- A role for heterologous gap junctions between melanoma and endothelial cells in metastasisJCI Insight, 2000